GMEQX Performance — GMO U.S. Equity Fund
Data updated: 2026-09-29
GMEQX returned +15.75% year to date and +43.31% over one year to May 2026. Annualised returns are +25.64% over 3 years and +14.98% over 5 years. The fund beat its US Large Blend category average: $100 invested three years ago grew to $198, against $165 for the category, and to $143 over one year, against $122. Volatility over the past three years was 14.39% a year. In the 12 months to May 2026 the fund lost a net $17.7M, and assets reached $220.16M. Returns are those of sibling share class GMUEX; this class's own returns are not reported in filings.
GMEQX Growth of $100
What $100 invested in GMO U.S. Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Blend category average over the same months.
| Period | GMEQX | Category average |
|---|---|---|
| 1 year (Jun 2025 – May 2026) | $143 | $122 |
| 3 years (Jun 2023 – May 2026) | $198 | $165 |
| 5 years (Jun 2021 – May 2026) | $201 | $164 |
| Since data start (Sep 2019 – May 2026) | $302 | $229 |
GMEQX Trailing Returns
Total returns to May 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +15.75% |
| 1 year | +43.31% |
| 3 years (annualised) | +25.64% |
| 5 years (annualised) | +14.98% |
GMEQX Annual Returns
Calendar-year total returns of GMO U.S. Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–May) | +15.75% |
| 2025 | +22.26% |
| 2024 | +20.92% |
| 2023 | +21.89% |
| 2022 | −12.45% |
| 2021 | +32.13% |
| 2020 | +13.70% |
| 2019 (Sep–Dec) | +10.03% |
GMEQX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.4% | −0.5% | −4.9% | +10.5% | +7.0% | — | — | — | — | — | — | — |
| 2025 | +3.9% | −2.9% | −6.5% | −1.7% | +6.5% | +5.6% | +1.6% | +3.7% | +4.3% | +2.9% | +2.1% | +1.5% |
| 2024 | +0.8% | +5.9% | +5.2% | −5.0% | +5.7% | +1.8% | +2.3% | +0.7% | +1.3% | −0.8% | +5.5% | −3.5% |
| 2023 | +6.3% | −1.8% | +2.1% | +0.5% | −1.8% | +7.1% | +3.2% | −2.4% | −3.4% | −2.7% | +8.6% | +5.3% |
| 2022 | −4.8% | −2.4% | +2.4% | −5.7% | +1.1% | −8.2% | +8.7% | −3.9% | −8.7% | +9.7% | +6.5% | −5.7% |
| 2021 | +1.0% | +5.0% | +6.7% | +4.1% | +1.9% | +0.2% | +1.7% | +2.8% | −5.5% | +5.3% | −0.5% | +6.1% |
| 2020 | −1.3% | −8.7% | −12.5% | +12.0% | +5.2% | +1.6% | +4.4% | +4.5% | −2.9% | −3.2% | +11.3% | +5.4% |
| 2019 | — | — | — | — | — | — | — | — | +2.7% | +1.3% | +3.6% | +2.2% |
GMEQX Risk
Risk measures from monthly returns over Jun 2023 – May 2026.
- 3-year volatility (annualised): 14.39%
- 3-year Sharpe ratio: 1.47 (vs 4.5% risk-free rate)
- Best month: +10.46% (Apr 2026)
- Worst month: −6.45% (Mar 2025)
GMEQX Fund Flows
Monthly money in and out of GMO U.S. Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$17.7M
- 12-month gross sales (incl. reinvestments): $31.5M
- Sales ÷ redemptions: 0.64×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| May 2026 | $0 | $3.9M | −$3.9M |
| Apr 2026 | $1.7M | $1.9M | −$236K |
| Mar 2026 | $425K | $16.5M | −$16.1M |
| Feb 2026 | $1.5M | $73K | $1.4M |
| Jan 2026 | $1.1M | $12K | $1.1M |
| Dec 2025 | $17.2M | $2.8M | $14.3M |
| Nov 2025 | $1.5M | $3.1M | −$1.5M |
| Oct 2025 | $0 | $4.3M | −$4.3M |
| Sep 2025 | $5K | $1.6M | −$1.6M |
| Aug 2025 | $0 | $3.5M | −$3.5M |
| Jul 2025 | $8.2M | $2.1M | $6.1M |
| Jun 2025 | $0 | $9.4M | −$9.4M |
GMEQX Assets Under Management
Net assets of GMO U.S. Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-05-31 | $220.16M |
| 2026-02-28 | $216.13M |
| 2025-11-30 | $205.47M |
| 2025-08-31 | $194.50M |
| 2025-05-31 | $188.97M |
| 2025-02-28 | $146.89M |
| 2024-11-30 | $141.63M |
| 2024-08-31 | $136.40M |
| 2024-05-31 | $132.77M |
| 2024-02-29 | $135.33M |
| 2023-11-30 | $267.76M |
| 2023-08-31 | $265.30M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.